In contrast, other studies have shown that IL-6 activates, proliferates, and increases the survival rates of lymphocytes during the immune response, suggesting a dual face of IL-6 in regulating various signaling pathways in the tumor microenvironment (Fisher et al., 2014). This evidence concerns the gene IL6 and neoplasm.